TL;DR
- Idea: A decentralized launchpad and liquidity protocol empowering global communities to fund, govern, and co-own biotech research through tokenized BioDAOs.
- Catalyst: V1 upgrade on Base and Solana, growing TVL, upcoming BioAgent deployments, and expanding DeSci adoption.
- Risks: Regulatory uncertainty in biotech tokens, adoption challenges of DeSci model, significant token unlocks causing volatility.
- Score: 8.00/ 10
Coin
- Name/ Ticker: Bio Protocol (BIO)
- Segment: DeSci
- Status: live
- Price: $0.248100
Key Metrics
- Market Cap: $496 142 300
- FDV: $825 115 744
- Circulating Supply: 1 996 316 815
- Total Supply: 3 320 000 000
Sources
Technology
- USP: Sustainable funding engine via trading fees and decentralized BioDAO launchpad for scientific IP.
- Core Technology: Multi-chain architecture combining Ethereum/Base smart contracts with Solana programs, decentralized AI research agents (BioAgents), and liquidity engine.
Roadmap
- 2025-04-01: V1 protocol upgrade launched
- 2025-05-28: Major token unlock releasing 339M BIO
- 2025-01-03: Launch of BIO Genesis public auction phase
- 2024-12-24: Binance Launchpool integration
- 2024-11-08: Strategic investment by Binance Labs
- 2024-11-18: Binance Labs investment announced
- 2023-12-01: HairDAO files first scientific patent
- 2023-11-01: Aggregate BioDAO market cap crosses $200M
- 2023-06-01: First IP-Token launch from Newcastle University
- 2022-12-01: Pfizer Ventures backs VitaDAO with $4.1M
- 2021-08-01: First science funded onchain with University of Copenhagen
Team & Investors
Team
- Co-Founder & Head of Tokenomics β Paul Kohlhaas:
- Co-Founder & R&D Lead β James Sinka:
- Legal Counsel β Jose Pinto:
- Product Lead β Leonard Boltz:
- Growth & Marketing β Nate Hindman:
- Operations Manager β Stefano Glauser:
- Co-Founder β Clemens Ortlepp:
Investors
- Binance Labs β Strategic β’ 2024-11-08
- 1kx β Genesis Round 1 β’ 2025-01-03 β’ $6.00M
- Boost VC β Genesis Round 1 β’ 2025-01-03 β’ $6.00M
- Northpond Ventures β Genesis Round 1 β’ 2025-01-03 β’ $6.00M
- Zee Prime Capital β Genesis Round 2 β’ 2024-11-14
- Kosmos Ventures β Genesis Round 2 β’ 2024-11-14
- Panga Capital β Genesis Round 2 β’ 2024-11-14
Total funding: $13.00M
Tokenomics
- Utility: Governance, staking/veBIO, curation of BioDAOs, BioAgent operations, access to launchpad allocations.
- Vesting: Core Contributors: 6-year vesting; Investors: 1-year cliff, 4-year vesting.
Pros & Cons
Strengths
- First-mover in decentralized biotech funding
- Strong institutional backing (Binance Labs, 1kx)
- Hybrid multi-chain design ensures scalability
- Innovative liquidity engine aligns incentives
- Robust token utility across governance and funding
- Active BioDAO network driving real use cases
- Positive market momentum and high trading volume
Weaknesses
- Novel DeSci concept with uncertain adoption
- Regulatory ambiguity around scientific tokens
- Upcoming token unlocks may pressure price
- High dependency on ecosystem growth
- Competition from other launchpad models
- Potential governance centralization risks
- Network gas fees on Ethereum may deter users
Market Signals (7d)
- TVL trend: up
- CEX volume trend: up
Price Scenarios (target: 2026-02-25)
- Bear: $0.100000 β 50% drawdown scenario based on sector-wide correction assumptions
- Base: $0.300000 β 20% growth aligned with projected DeSci adoption and milestone delivery
- Bull: $0.500000 β 2x current price driven by successful protocol upgrades and mainstream DeSci uptake
How to Buy & Store
CEX
- Binance
- Coinbase
- MEXC
- Deepcoin
- OKX
DEX
- Uniswap
- SushiSwap
- Raydium
- PancakeSwap
- 1inch
Storage
- MetaMask
- Ledger
- Trust Wallet
- Solflare
- Argent
Verdict
Bio Protocol combines innovative DeSci infrastructure with strong investor backing, offering significant upside but facing sector adoption and regulatory risks.
Official Links
Source: Coin Research (internal)
Comments (0)